Updated on 2024/05/17

写真a

 
Shinji Watanabe
 
Affiliation
Nippon Medical School Hospital, Department of Allergy and Rheumatology, Assistant Professor
Title
Assistant Professor
External link

Research Areas

  • Life Science / Connective tissue disease and allergy

Education

  • Niigata University   Faculty of Medicine   School of Medicine

      More details

Research History

Professional Memberships

Papers

  • Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate. International journal

    Ryuta Uraki, Mutsumi Ito, Maki Kiso, Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Yuko Sakai-Tagawa, Masaki Imai, Michiko Koga, Shinya Yamamoto, Eisuke Adachi, Makoto Saito, Takeya Tsutsumi, Amato Otani, Shuetsu Fukushi, Shinji Watanabe, Tadaki Suzuki, Tetsuhiro Kikuchi, Hiroshi Yotsuyanagi, Ken Maeda, Yoshihiro Kawaoka

    iScience   26 ( 11 )   108147 - 108147   2023.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The emergence and spread of new SARS-CoV-2 variants with mutations in the spike protein, such as the XBB.1.5 and XBB.1.9.1 sublineages, raise concerns about the efficacy of current COVID-19 vaccines and therapeutic monoclonal antibodies (mAbs). In this study, none of the mAbs we tested neutralized XBB.1.9.1 or XBB.1.5, even at the highest concentration used. We also found that the bivalent mRNA vaccine could enhance humoral immunity against XBB.1.9.1, but that XBB.1.9.1 and XBB.1.5 still evaded humoral immunity induced by vaccination or infection. Moreover, the susceptibility of XBB.1.9.1 to remdesivir, molnupiravir, nirmatrelvir, and ensitrelvir was similar to that of the ancestral strain and the XBB.1.5 isolate in vitro. Finally, we found the replicative fitness of XBB.1.9.1 to be similar to that of XBB.1.5 in hamsters. Our results suggest that XBB.1.9.1 and XBB.1.5 have similar antigenicity and replicative ability, and that the currently available COVID-19 antivirals remain effective against XBB.1.9.1.

    DOI: 10.1016/j.isci.2023.108147

    PubMed

    researchmap

  • 抗MDA5抗体陽性若年性皮膚筋炎の一例

    鈴木 幹人, 佐々木 信人, 吉田 晃, 渡邊 晋二, 白井 悠一郎, 五野 貴久, 桑名 正隆

    関東リウマチ   55   52 - 55   2023.5

     More details

    Language:Japanese   Publisher:関東リウマチ研究会  

    症例は10歳男児で、多関節痛、筋力低下、紅斑を主訴とした。入院時身体所見、皮膚所見、血液検査、画像所見より抗MDA5抗体陽性若年性皮膚筋炎と診断した。主体は皮膚・筋・関節病変で、間質性肺炎は軽微であった。メチルプレドニゾロン(mPSL)投与後、PSL、シクロフォスファミド間欠静注療法を行った。治療開始2週間後に関節症状の速やかな改善・CDASI低下・CMAS上昇、3ヵ月後に左上葉すりガラス影の消失を認めた。

    researchmap

  • Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: implications for vaccine dose interval

    Sho Miyamoto, Yudai Kuroda, Takayuki Kanno, Akira Ueno, Nozomi Shiwa-Sudo, Naoko Iwata-Yoshikawa, Yusuke Sakai, Noriyo Nagata, Takeshi Arashiro, Akira Ainai, Saya Moriyama, Noriko Kishida, Shinji Watanabe, Kiyoko Nojima, Yohei Seki, Takuo Mizukami, Hideki Hasegawa, Hideki Ebihara, Shuetsu Fukushi, Yoshimasa Takahashi, Maeda Ken, Tadaki Suzuki

    iScience   106694 - 106694   2023.4

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.isci.2023.106694

    researchmap

  • Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates. International journal

    Ryuta Uraki, Shun Iida, Peter J Halfmann, Seiya Yamayoshi, Yuichiro Hirata, Kiyoko Iwatsuki-Horimoto, Maki Kiso, Mutsumi Ito, Yuri Furusawa, Hiroshi Ueki, Yuko Sakai-Tagawa, Makoto Kuroda, Tadashi Maemura, Taksoo Kim, Sohtaro Mine, Noriko Iwamoto, Rong Li, Yanan Liu, Deanna Larson, Shuetsu Fukushi, Shinji Watanabe, Ken Maeda, Zhongde Wang, Norio Ohmagari, James Theiler, Will Fischer, Bette Korber, Masaki Imai, Tadaki Suzuki, Yoshihiro Kawaoka

    Nature communications   14 ( 1 )   1620 - 1620   2023.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The prevalence of the Omicron subvariant BA.2.75 rapidly increased in India and Nepal during the summer of 2022, and spread globally. However, the virological features of BA.2.75 are largely unknown. Here, we evaluated the replicative ability and pathogenicity of BA.2.75 clinical isolates in Syrian hamsters. Although we found no substantial differences in weight change among hamsters infected with BA.2, BA.5, or BA.2.75, the replicative ability of BA.2.75 in the lungs is higher than that of BA.2 and BA.5. Of note, BA.2.75 causes focal viral pneumonia in hamsters, characterized by patchy inflammation interspersed in alveolar regions, which is not observed in BA.5-infected hamsters. Moreover, in competition assays, BA.2.75 replicates better than BA.5 in the lungs of hamsters. These results suggest that BA.2.75 can cause more severe respiratory disease than BA.5 and BA.2 in a hamster model and should be closely monitored.

    DOI: 10.1038/s41467-023-37059-x

    PubMed

    researchmap

  • Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents. International journal

    Ryuta Uraki, Peter J Halfmann, Shun Iida, Seiya Yamayoshi, Yuri Furusawa, Maki Kiso, Mutsumi Ito, Kiyoko Iwatsuki-Horimoto, Sohtaro Mine, Makoto Kuroda, Tadashi Maemura, Yuko Sakai-Tagawa, Hiroshi Ueki, Rong Li, Yanan Liu, Deanna Larson, Shuetsu Fukushi, Shinji Watanabe, Ken Maeda, Andrew Pekosz, Ahmed Kandeil, Richard J Webby, Zhongde Wang, Masaki Imai, Tadaki Suzuki, Yoshihiro Kawaoka

    Nature   612 ( 7940 )   540 - 545   2022.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The BA.2 sublineage of the SARS-CoV-2 Omicron variant has become dominant in most countries around the world; however, the prevalence of BA.4 and BA.5 is increasing rapidly in several regions. BA.2 is less pathogenic in animal models than previously circulating variants of concern1-4. Compared with BA.2, however, BA.4 and BA.5 possess additional substitutions in the spike protein, which play a key role in viral entry, raising concerns that the replication capacity and pathogenicity of BA.4 and BA.5 are higher than those of BA.2. Here we have evaluated the replicative ability and pathogenicity of BA.4 and BA.5 isolates in wild-type Syrian hamsters, human ACE2 (hACE2) transgenic hamsters and hACE2 transgenic mice. We have observed no obvious differences among BA.2, BA.4 and BA.5 isolates in growth ability or pathogenicity in rodent models, and less pathogenicity compared to a previously circulating Delta (B.1.617.2 lineage) isolate. In addition, in vivo competition experiments revealed that BA.5 outcompeted BA.2 in hamsters, whereas BA.4 and BA.2 exhibited similar fitness. These findings suggest that BA.4 and BA.5 clinical isolates have similar pathogenicity to BA.2 in rodents and that BA.5 possesses viral fitness superior to that of BA.2.

    DOI: 10.1038/s41586-022-05482-7

    PubMed

    researchmap

  • Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination

    Emi Takashita, Seiya Yamayoshi, Shuetsu Fukushi, Tadaki Suzuki, Ken Maeda, Yuko Sakai-Tagawa, Mutsumi Ito, Ryuta Uraki, Peter Halfmann, Shinji Watanabe, Makoto Takeda, Hideki Hasegawa, Masaki Imai, Yoshihiro Kawaoka

    New England Journal of Medicine   387 ( 13 )   1234 - 1236   2022.9

  • Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75. International journal

    Emi Takashita, Seiya Yamayoshi, Shuetsu Fukushi, Tadaki Suzuki, Ken Maeda, Yuko Sakai-Tagawa, Mutsumi Ito, Ryuta Uraki, Peter Halfmann, Shinji Watanabe, Makoto Takeda, Hideki Hasegawa, Masaki Imai, Yoshihiro Kawaoka

    The New England journal of medicine   387 ( 13 )   1236 - 1238   2022.9

     More details

  • Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2. International journal

    Hirofumi Ohashi, Takayuki Hishiki, Daisuke Akazawa, Kwang Su Kim, Joohyeon Woo, Kaho Shionoya, Kana Tsuchimoto, Shoya Iwanami, Saya Moriyama, Hitomi Kinoshita, Souichi Yamada, Yudai Kuroda, Tsukasa Yamamoto, Noriko Kishida, Shinji Watanabe, Hideki Hasegawa, Hideki Ebihara, Tadaki Suzuki, Ken Maeda, Shuetsu Fukushi, Yoshimasa Takahashi, Shingo Iwami, Koichi Watashi

    Antiviral research   205   105372 - 105372   2022.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariant BA.2 has spread in many countries, replacing the earlier Omicron subvariant BA.1 and other variants. Here, using a cell culture infection assay, we quantified the intrinsic sensitivity of BA.2 and BA.1 compared with other variants of concern, Alpha, Gamma, and Delta, to five approved-neutralizing antibodies and antiviral drugs. Our assay revealed the diverse sensitivities of these variants to antibodies, including the loss of response of both BA.1 and BA.2 to casirivimab and of BA.1 to imdevimab. In contrast, EIDD-1931 and nirmatrelvir showed a more conserved activities to these variants. The viral response profile combined with mathematical analysis estimated differences in antiviral effects among variants in the clinical concentrations. These analyses provide essential evidence that gives insight into variant emergence's impact on choosing optimal drug treatment.

    DOI: 10.1016/j.antiviral.2022.105372

    PubMed

    researchmap

  • Recommendations for the execution and reporting of skin ultrasound in systemic sclerosis: an international collaboration under the WSF skin ultrasound group. International journal

    Tânia Santiago, Eduardo José Ferreira Santos, Barbara Ruaro, Gemma Lepri, Lorraine Green, Marie Wildt, Shinji Watanabe, Alain Lescoat, Roger Hesselstrand, Francesco Del Galdo, John D Pauling, Lucy Jean Reeve, Maria Antonieta D'Agostino, Marco Matucci-Cerinic, Annamaria Iagnocco, Jose Antonio Pereira da Silva

    RMD open   8 ( 2 )   2022.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: Ultrasound is a promising tool to foster much-needed improvement of skin assessment in systemic sclerosis (SSc). Our aim was to develop evidence and expert opinion-based recommendations to promote the standardisation and harmonisation of technical execution and reporting of skin ultrasound studies in SSc. METHODS: A multidisciplinary task force of 16 members from five European countries and Japan was convened under the auspices of World Scleroderma Foundation. First, a systematic literature review (SLR) was performed. Then, each member proposed and formulated items to the overarching principles, recommendations and research agenda. Two rounds of mails exchange for consensus as well as an on-line meeting were performed to debate and refine the proposals. Two Delphi rounds of voting resulted in the final recommendations. Levels of evidence and strengths of recommendations were assigned, and task force members voted anonymously on the level of agreement with each of the items. RESULTS: Five overarching principles and seven recommendations were developed, based on an SLR and expert opinion, through consensus procedures. The overarching principles highlight the promising role of skin ultrasound in SSc assessment, the need for standardisation of technical aspects, sufficient training and adequate equipment. The recommendations provide standards for the execution and reporting of skin ultrasound in SSc. The research agenda includes the need for more research into unmet needs according to Outcome Measures in Rheumatology Algorithm requirements. CONCLUSION: These are the first recommendations providing guidance on the execution and reporting of skin ultrasound in SSc patients, aiming at improving the interpretability, reliability and generalisability of skin ultrasound, thus consolidating its role in research and practice.

    DOI: 10.1136/rmdopen-2022-002371

    PubMed

    researchmap

  • Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants. International journal

    Sho Miyamoto, Takeshi Arashiro, Yu Adachi, Saya Moriyama, Hitomi Kinoshita, Takayuki Kanno, Shinji Saito, Harutaka Katano, Shun Iida, Akira Ainai, Ryutaro Kotaki, Souichi Yamada, Yudai Kuroda, Tsukasa Yamamoto, Keita Ishijima, Eun-Sil Park, Yusuke Inoue, Yoshihiro Kaku, Minoru Tobiume, Naoko Iwata-Yoshikawa, Nozomi Shiwa-Sudo, Kenzo Tokunaga, Seiya Ozono, Takuya Hemmi, Akira Ueno, Noriko Kishida, Shinji Watanabe, Kiyoko Nojima, Yohei Seki, Takuo Mizukami, Hideki Hasegawa, Hideki Ebihara, Ken Maeda, Shuetsu Fukushi, Yoshimasa Takahashi, Tadaki Suzuki

    Med (New York, N.Y.)   3 ( 4 )   249 - 261   2022.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: The immune profile against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has dramatically diversified due to a complex combination of exposure to vaccines and infection by various lineages/variants, likely generating a heterogeneity in protective immunity in a given population. To further complicate this, the Omicron variant, with numerous spike mutations, has emerged. These circumstances have created the need to assess the potential of immune evasion by Omicron in individuals with various immune histories. Methods: The neutralization susceptibility of the variants, including Omicron and their ancestors, was comparably assessed using a panel of plasma/serum derived from individuals with divergent immune histories. Blood samples were collected from either mRNA vaccinees or from those who suffered from breakthrough infections of Alpha/Delta with multiple time intervals following vaccination. Findings: Omicron was highly resistant to neutralization in fully vaccinated individuals without a history of breakthrough infections. In contrast, robust cross-neutralization against Omicron was induced in vaccinees that experienced breakthrough infections. The time interval between vaccination and infection, rather than the variant types of infection, was significantly correlated with the magnitude and potency of Omicron-neutralizing antibodies. Conclusions: Immune histories with breakthrough infections can overcome the resistance to infection by Omicron, with the vaccination-infection interval being the key determinant of the magnitude and breadth of neutralization. The diverse exposure history in each individual warrants a tailored and cautious approach to understanding population immunity against Omicron and future variants. Funding: This study was supported by grants from the Japan Agency for Medical Research and Development (AMED).

    DOI: 10.1016/j.medj.2022.02.006

    PubMed

    researchmap

  • Ultrasound and elastography in the assessment of skin involvement in systemic sclerosis: A systematic literature review focusing on validation and standardization - WSF Skin Ultrasound Group. International journal

    Tânia Santiago, Eduardo Santos, Barbara Ruaro, Gemma Lepri, Lorraine Green, Marie Wildt, Shinji Watanabe, Alain Lescoat, Roger Hesselstrand, Francesco Del Galdo, John D Pauling, Annamaria Iagnocco, Jap da Silva

    Seminars in arthritis and rheumatism   52   151954 - 151954   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To summarize the published evidence in the literature on the role of ultrasound and elastography to assess skin involvement in systemic sclerosis (SSc). METHODS: A systematic literature review (SLR) was performed within the "Skin Ultrasound Working Group" of the World Scleroderma Foundation, according to the Cochrane Handbook. A search was conducted in Pubmed, Cochrane Library and Embase databases from 1/1/1979 to 31/5/2021, using the participants, intervention, comparator and outcomes (PICO) framework. Only full-text articles involving adults, reported in any language, assessing ultrasound to quantify skin pathology in SSc patients. Two reviewers performed the assessment of risk of bias, data extraction and synthesis, independently. RESULTS: Forty-six studies out of 3248 references evaluating skin ultrasound and elastography domains were included. B-mode ultrasound was used in 30 studies (65.2%), elastography in nine (19.6%), and both methods in seven (15.2%). The ultrasound outcome measure domains reported were thickness (57.8%) and echogenicity (17.2%); the elastography domain was stiffness (25%). Methods used for image acquisition and analysis were remarkably heterogeneous and frequently under-reported, precluding data synthesis across studies. The same applies to contextual factors and feasibility. Our data syntheses indicated evidence of good reliability and convergent validity for ultrasound thickness evaluation against mRSS and skin histological findings. Stiffness and echogenicity have limited evidence for validity against histological findings. Evidence for sensitivity to change, test-retest reliability, clinical trial discrimination or thresholds of meaning is limited or absent for reported ultrasound domains. CONCLUSION: Ultrasound is a valid and reliable tool for skin thickness measurement in SSc but there are significant knowledge gaps regarding skin echogenicity assessment by ultrasound and skin stiffness evaluation by elastography in terms of feasibility, validity and discrimination. Standardization of image acquisition and analysis is needed to foster progress.

    DOI: 10.1016/j.semarthrit.2022.151954

    PubMed

    researchmap

  • Infratentorial onset of progressive multifocal leukoencephalopathy in a patient with systematic lupus erythematosus complicated with lymphoma: a case report. Reviewed International journal

    Mita Sakuraba, Shinji Watanabe, Yasuhiro Nishiyama, Kenta Takahashi, Kazuo Nakamichi, Mikito Suzuki, Takashi Nawata, Kota Komai, Takahisa Gono, Mitsuhiro Takeno, Tadaki Suzuki, Kazumi Kimura, Masataka Kuwana

    Modern rheumatology case reports   5 ( 2 )   272 - 277   2021.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Progressive multifocal leukoencephalopathy (PML) is a rare opportunistic infection of the central nervous system caused by reactivation of JC virus (JCV). Typical PML shows confluent, bilateral but asymmetric, subcortical lesions in the supratentorial white matter on magnetic resonance imaging (MRI). We report here a 50-year-old woman with systemic lupus erythematosus complicated with lymphoma who developed PML with atypical brain MRI findings limited to the infratentorial area at presentation. She presented with numbness on the right side of the face, including her tongue, clumsiness of the right hand, and gait disturbance, after completion of remission induction therapy for lymphoma, including rituximab. Brain MRI demonstrated a solitary lesion limited to the cerebellum and brainstem, but a definitive diagnosis could not be made from cerebrospinal fluid study or tentative histologic evaluation of brain biopsy specimens. Despite methylprednisolone pulse therapy, her neurological deficits progressively worsened. One month later, in-depth analysis of her cerebrospinal fluid and brain biopsy specimens confirmed the presence of JCV. Eventually, the localised unilateral crescent-shaped cerebellar lesions on MRI expanded to the contralateral cerebellum, middle cerebellar hemisphere, pons, and midbrain and finally developed multifocal invasion into the white matter of the cerebral hemispheres. Our case suggests that PML could first present with a solitary infratentorial lesion in immunocompromised patients.

    DOI: 10.1080/24725625.2021.1899763

    PubMed

    researchmap

  • The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancement Reviewed

    Michael Hughes, Cosimo Bruni, Giovanna Cuomo, Andrea Delle Sedie, Luna Gargani, Marwin Gutierrez, Gemma Lepri, Barbara Ruaro, Tania Santiago, Yossra Suliman, Shinji Watanabe, Annamaria Iagnocco, Daniel Furst, Silvia Bellando-Randone

    Journal of Scleroderma and Related Disorders   239719832097039 - 239719832097039   2020.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:SAGE Publications  

    Ultrasound has been widely explored in systemic sclerosis in the clinical and research settings. Ultrasound allows a non-invasive and ionising radiation-free ‘window’ into this complex disease and is well-suited to repeated examinations. Ultrasound provides novel insights into the pathogenesis and measurement of disease in systemic sclerosis, including early (preclinical) internal organ involvement. The purpose of this review is to describe the role of ultrasound to foster clinical and research advancements in systemic sclerosis relating to (1) musculoskeletal, (2) digital ulcer, (3) lung disease and (4) skin disease. We also highlight unmet needs which much be addressed for ultrasound to assume a central role in systemic sclerosis clinical care and research.

    DOI: 10.1177/2397198320970394

    researchmap

    Other Link: http://journals.sagepub.com/doi/full-xml/10.1177/2397198320970394

  • 膠原病に伴う間質性肺疾患における肺エコーの有用性

    渡邊 晋二, 山崎 宜興, 五野 貴久, 桑名 正隆

    日本医科大学医学会雑誌   16 ( 4 )   259 - 260   2020.10

     More details

    Language:Japanese   Publisher:日本医科大学医学会  

    researchmap

  • 眼窩筋炎を伴ったSLEの一例

    先崎 香朱実, 渡邊 晋二, 鈴木 幹人, 櫻庭 未多, 小林 政司, 白井 悠一郎, 五野 貴久, 岳野 光洋, 桑名 正隆

    日本臨床免疫学会総会プログラム・抄録集   48回   106 - 106   2020.10

     More details

    Language:Japanese   Publisher:日本臨床免疫学会  

    researchmap

  • 眼窩筋炎を伴ったSLEの一例

    先崎 香朱実, 渡邊 晋二, 鈴木 幹人, 櫻庭 未多, 小林 政司, 白井 悠一郎, 五野 貴久, 岳野 光洋, 桑名 正隆

    日本臨床免疫学会総会プログラム・抄録集   48回   106 - 106   2020.10

     More details

    Language:Japanese   Publisher:(一社)日本臨床免疫学会  

    researchmap

  • 手指壊疽を呈した抗アミノアシルtRNA合成酵素(ARS)抗体陽性の一例

    吉田 晃, 五野 貴久, 福栄 亮介, 川端 真里佐, 内山 竣介, 渡邊 晋二, 小林 政司, 白井 悠一郎, 岳野 光洋, 桑名 正隆

    日本リウマチ学会関東支部学術集会プログラム・抄録集   30回   71 - 71   2019.12

     More details

    Language:Japanese   Publisher:日本リウマチ学会-関東支部  

    researchmap

  • 小脳・脳幹病変初発の進行性多巣性白質脳症を合併した全身性エリテマトーデスの1例

    櫻庭 未多, 渡邊 晋二, 鈴木 幹人, 名和田 隆司, 五野 貴久, 桑名 正隆, 駒井 侯太, 須田 智, 西山 康裕, 木村 和美, 田村 秀人

    日本医科大学医学会雑誌   15 ( 4 )   267 - 267   2019.10

     More details

    Language:Japanese   Publisher:日本医科大学医学会  

    researchmap

  • Unclassified Vasculitis with Episcleritis, Thrombophlebitis, Deep Vein Thrombosis, Pulmonary Vasculitis, and Intracranial Vasculitis: An Autopsy Case Report. Reviewed

    Watanabe E, Tanaka A, Sugawara H, Nishina K, Yabe H, Gono T, Terai C

    The American journal of case reports   20   886 - 895   2019.6

     More details

    Publishing type:Research paper (scientific journal)   Publisher:International Scientific Information, Inc.  

    DOI: 10.12659/AJCR.915527

    PubMed

    researchmap

  • Scleroderma renal crisis with coexisting segmental arterial mediolysis presenting as intraperitoneal bleeding: a case report Reviewed

    Kaneko S, Watanabe E, Abe M, Watanabe S, Yabe H, Kojima S, Takagi K, Hirai K, Morishita Y, Terai C

    Journal of medicine case report   20 ( 13 )   74   2019.3

     More details

    Language:English  

    researchmap

  • 多発性筋炎・皮膚筋炎-4 同時性重複癌を有する悪性腫瘍関連筋炎の臨床的検討

    櫻庭 未多, 門田 寛子, 五野 貴久, 山口 由衣, 渡邉 萌理, 岡崎 有佳, 渡邊 晋二, 白井 悠一郎, 小林 政司, 岳野 光洋, 寺井 千尋, 桑名 正隆

    日本リウマチ学会総会・学術集会プログラム・抄録集   63回   552 - 552   2019.3

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • シェーグレン症候群 免疫チェックポイント阻害薬投与後に発症したSjoegren症候群の臨床的特徴

    鈴木 幹人, 五野 貴久, 渡邊 晋二, 白井 悠一郎, 小林 政司, 岳野 光洋, 桑名 正隆

    日本リウマチ学会総会・学術集会プログラム・抄録集   63回   523 - 523   2019.3

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 血管炎(ANCA関連血管炎)-1 ANCA関連血管炎患者における中耳炎の予測因子の検討

    小林 政司, 門田 寛子, 渡邊 晋二, 白井 悠一郎, 五野 貴久, 岳野 光洋, 桑名 正隆

    日本リウマチ学会総会・学術集会プログラム・抄録集   63回   454 - 454   2019.3

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 治療抵抗性の視神経炎にリツキシマブ投与を行ったANCA関連血管炎の一例

    渡邉 萌理, 阿部 麻衣, 渡邊 晋二, 矢部 寛樹, 小橋川 剛, 小竹 茂, 寺井 千尋

    関東リウマチ   52   10 - 14   2019.3

     More details

    Language:Japanese   Publisher:関東リウマチ研究会  

    70歳女性。7ヵ月前にANCA関連血管炎性中耳炎(OMAAV)を発症し、ステロイド(PSL)による治療を開始した。治療開始後は難聴の著明な改善を認めたが、PSLの漸減により右眼の視野障害、眼痛が出現した。右球後視神経炎の診断でステロイドパルス、PSL治療を受け症状は改善し、POCYを追加されるも視神経炎が再燃したたため当科入院となった。入院後はPSL、IVCYを行い、症状は一時改善したが、入院4ヵ月後に視神経炎とOMAAVが再燃したため、リツキシマブ投与を4コース行ったところ、症状は改善した。現在、メソトレキセートを追加し、再燃なく経過している。

    researchmap

  • 重篤な経過をたどった若年性ANCA関連血管炎の一例

    渡邉 萌理, 杉谷 直大, 阿部 麻衣, 渡邊 晋二, 矢部 寛樹, 寺井 千尋

    関東リウマチ   ( 51 )   78 - 82   2018.2

     More details

    Language:Japanese   Publisher:関東リウマチ研究会  

    researchmap

  • 重篤な経過をたどった若年性ANCA関連血管炎の一例

    渡邉 萌理, 杉谷 直大, 阿部 麻衣, 渡邊 晋二, 矢部 寛樹, 寺井 千尋

    関東リウマチ   51   78 - 82   2018.2

     More details

    Language:Japanese   Publisher:関東リウマチ研究会  

    症例は26歳女性で、2年前に移動性の単関節炎、1年前に左難聴が出現した。3ヵ月前に有痛性の口内炎が多発、両膝関節痛が増悪し歩行困難となった。その後、褐色尿、鼻出血、四肢の紫斑、眼球結膜充血、咽頭痛が出現し、呼吸困難と喀血がみられたため当院転院となった。病歴でみられた症状と得られた所見を多発血管炎性肉芽腫症(GPA)の診断基準に当てはめると、主要症状、組織所見、検査所見すべてを満たしたため、診断はGPAに半月体形成性糸球体腎炎とび漫性肺胞出血を伴う肺腎症候群と考えられた。まずステロイドパルス療法を行い、血漿交換も併用し、その後VVECMOを装着した。徐々に肺胞出血が改善し、炎症所見やANCAのtiterも低下し、ECMO導入から12日間で離脱した。人工呼吸器からも離脱し、酸素投与を終了した。腎機能障害の著明な改善がみられたため透析を終了し、67日目に退院した。

    researchmap

  • Rheumatoid factor is correlated with disease activity and inflammatory markers in antineutrophil cytoplasmic antibody-associated vasculitis Reviewed

    Shinji Watanabe, Takahisa Gono, Kumiko Nishina, Naohiro Sugitani, Eri Watanabe, Hiroki Yabe, Chihiro Terai

    BMC IMMUNOLOGY   18 ( 1 )   53   2017.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BIOMED CENTRAL LTD  

    Background: Some patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) also have positivity of rheumatoid factor (RF). However, the clinical significance of this occurrence remains unknown in AAV patients. The aim of this study was to clarify an association between the presence of RF and clinical features in patients with AAV.
    Results: Forty-seven patients diagnosed with AAV who were not complicated with RA were enrolled in this study. We compared clinical manifestations of AAV between an RF-positive subset (n = 29) and an RF-negative subset (n= 18). The Birmingham Vasculitis Activity Score (BVAS) was higher (P = 0.026) in the RF-positive subset than in the RF-negative subset. The levels of CRP and ESR were higher in the RF-positive patients (P = 0.020 and P = 0.007, respectively) compared to the RF-negative subset. IgM-RF titers were significantly correlated with the BVAS (r = 0.50, P = 0.0004). In addition, the IgM-RF titers had significant correlations with the levels of CRP (r= 0.41, P = 0.004), ESR (r = 0.39, P = 0.016), IgM (r = 0.36, P = 0.016) and IgG (r = 0.37, P = 0.015). The frequency of commencement of dialysis therapy, usage of mechanical ventilation and mortality were higher in the RF-positive subset than in the RF-negative subset.
    Conclusions: In patients with AAV, RF titers were significantly correlated with disease activity and the levels of inflammatory markers. The presence of RF could be a poor prognostic factor in patients with AAV.

    DOI: 10.1186/s12865-017-0234-8

    Web of Science

    PubMed

    researchmap

  • Analysis of Required Dose of Corticosteroid As Maintenance Therapy and Related Factors in Patients with Polymyositis/Dermatomyositis Reviewed

    Eri Watanabe, Takahisa Gono, Shinji Watanabe, Hiroki Yabe, Masataka Kuwana, Chihiro Terai

    ARTHRITIS & RHEUMATOLOGY   69   2017.10

     More details

    Language:English   Publisher:WILEY  

    Web of Science

    researchmap

  • Predictive Factors for Achievement of Sustained Remission with Polymyositis/Dermatomyositis: A Retrospective Single Center Cohort Study in Japan Reviewed

    Eri Watanabe, Takahisa Gono, Shinji Watanabe, Hiroki Yabe, Masataka Kuwana, Chihiro Terai

    ARTHRITIS & RHEUMATOLOGY   69   2017.10

     More details

    Language:English   Publisher:WILEY  

    Web of Science

    researchmap

  • 急性漿膜炎で発症した全身性エリテマトーデス(SLE)の1例

    塩谷 竜之介, 川村 愛, 森野 諄紀, 杉谷 直大, 渡辺 晋二, 渡辺 萌理, 石井 彰, 飯塚 悠祐, 菅原 斉, 寺井 千尋

    日本内科学会関東地方会   627回   46 - 46   2016.10

     More details

    Language:Japanese   Publisher:日本内科学会-関東地方会  

    researchmap

▼display all

Books

  • 日本臨床 第75巻・第12号

    渡邊晋二( Role: Contributor痛風関節炎の治療)

    日本臨床社  2017.12 

     More details

  • リウマチ科 第五十八巻第一号

    渡邊晋二( Role: Contributor腎障害を有する痛風患者に対するfebuxostatの有用性)

    2017.7 

     More details

Misc.

  • Estimating serum cross-neutralizing responses to SARS-CoV-2 Omicron sub-lineages elicited by pre-Omicron or Omicron breakthrough infection with exposure interval compensation modeling

    Sho Miyamoto, Yudai Kuroda, Takayuki Kanno, Akira Ueno, Nozomi Shiwa-Sudo, Naoko Iwata-Yoshikawa, Yusuke Sakai, Noriyo Nagata, Takeshi Arashiro, Akira Ainai, Saya Moriyama, Noriko Kishida, Shinji Watanabe, Kiyoko Nojima, Yohei Seki, Takuo Mizukami, Hideki Hasegawa, Hideki Ebihara, Shuetsu Fukushi, Yoshimasa Takahashi, Ken Maeda, Tadaki Suzuki

    medRxiv   2023.2

     More details

    Publisher:Cold Spring Harbor Laboratory  

    Abstract

    Understanding the differences in serum cross-neutralizing responses against SARS-CoV-2 variants, including Omicron sub-lineages BA.5, BA.2.75, and BQ.1.1, elicited by exposure to distinct antigens is essential for developing COVID-19 booster vaccines with enhanced cross-protection against antigenically distinct variants. However, fairly comparing the impact of breakthrough infection on serum neutralizing responses to several variants with distinct epidemic timing is challenging because responses after breakthrough infection are affected by the exposure interval between vaccination and infection. We assessed serum cross-neutralizing responses to SARS-CoV-2 variants, including Omicron sub-lineages, in individuals with breakthrough infections before or during the Omicron BA.1 epidemic. To understand the differences in serum cross-neutralizing responses after pre-Omicron or Omicron breakthrough infection, we used Bayesian hierarchical modeling to correct the cross-neutralizing responses for the exposure interval between vaccination and breakthrough infection. The exposure interval required to generate saturated cross-neutralizing potency against each variant differed by variant, with variants more antigenically distant from the ancestral strain requiring a longer interval. Additionally, Omicron breakthrough infection was estimated to have higher impact than booster vaccination and pre-Omicron breakthrough infection on inducing serum neutralizing responses to the ancestral strain and Omicron sub-lineages. However, the breadth of cross-neutralizing responses to Omicron sub-lineages, including BQ.1.1, after Omicron or pre-Omicron breakthrough infection with the ideal exposure interval were estimated to be comparable. Our results highlight the importance of optimizing the interval between vaccine doses for maximizing the breadth of cross-neutralizing activity elicited by booster vaccines with or without Omicron antigen.

    Significance Statement

    SARS-CoV-2 infections after vaccination with COVID-19 mRNA vaccines with the ancestral spike antigen induce high serum neutralizing responses against Omicron sub-lineages, which are antigenically distant from the ancestral antigen. In individuals with breakthrough infections, the exposure interval from vaccination to infection is critical for the induction of serum cross-neutralizing activity. We used statistical modeling to estimate the serum neutralizing response to Omicron sub-lineages corrected for the influence of different exposure intervals between vaccination and breakthrough infection in individuals with pre-Omicron and Omicron breakthrough infections. This enabled us to assess fairly the effects of exposure to distinct antigens on inducing serum cross-neutralizing responses with the ideal exposure interval, and revealed the clinical significance of optimizing the dose interval in COVID-19 booster vaccination.

    DOI: 10.1101/2023.02.08.23285673

    researchmap

  • 中下位頚椎病変による頚部痛が初発症状となった関節リウマチの一例

    齊藤有希子, 渡邊晋二, 吉田晃, 大田ゆう子, 白井悠一郎, 五野貴久, 岳野光洋, 桑名正隆

    関東リウマチ   54   2022

  • 膠原病における肺エコー(シンポジウム16 関節だけじゃない,膠原病疾患におけるエコー検査活用)

    渡邊晋二, 山崎宜興, 五野貴久, 桑名正隆

    日本リウマチ学会総会・学術集会プログラム・抄録集 64回   2021.4

     More details

  • 膠原病関連間質性肺疾患における肺エコーの有用性 -HRCTとの 相関性の検証-

    渡邊 晋二, 五野 貴久, 鈴木 幹人, 岳野 光洋, 桑名 正隆

    日本リウマチ学会総会・学術集会プログラム・抄録集 64回   64回   709 - 709   2020.8

     More details

    Authorship:Lead author   Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 血栓性微小血管障害(TMA)を主病態とした抗MDA5抗体陽性皮膚筋炎(DM)の1例

    渡邊 晋二, 五野 貴久, 川端 真里佐, 内山 竣介, 吉田 晃, 小林 政司, 白井 悠一郎, 岳野 光洋, 桑名 正隆

    日本リウマチ学会関東支部学術集会プログラム・抄録集   30回   64 - 64   2019.12

     More details

    Language:Japanese   Publisher:日本リウマチ学会-関東支部  

    researchmap

  • 小脳・脳幹病変初発の進行性多巣性白質脳症を合併した全身性エリテマトーデスの1例

    櫻庭 未多, 渡邊 晋二, 鈴木 幹人, 名和田 隆司, 五野 貴久, 桑名 正隆, 駒井 侯太, 須田 智, 西山 康裕, 木村 和美, 田村 秀人

    日本医科大学医学会雑誌   15 ( 4 )   267 - 267   2019.10

     More details

    Language:Japanese   Publisher:日本医科大学医学会  

    researchmap

  • 関節リウマチの合併症 既存肺病変を有する関節リウマチ患者における新規肺イベントに対する生物学的製剤の影響に関する検討

    渡邊 晋二, 五野 貴久, 白井 悠一郎, 小林 政司, 岳野 光洋, 桑名 正隆

    日本リウマチ学会総会・学術集会プログラム・抄録集   63回   457 - 457   2019.3

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 関節リウマチの合併症 既存肺病変を有する関節リウマチ患者における新規肺イベントに対する生物学的製剤の影響に関する検討

    渡邊 晋二, 五野 貴久, 白井 悠一郎, 小林 政司, 岳野 光洋, 桑名 正隆

    日本リウマチ学会総会・学術集会プログラム・抄録集   63回   457 - 457   2019.3

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 血管炎(ANCA関連血管炎)-1 ANCA関連血管炎患者における中耳炎の予測因子の検討

    小林 政司, 門田 寛子, 渡邊 晋二, 白井 悠一郎, 五野 貴久, 岳野 光洋, 桑名 正隆

    日本リウマチ学会総会・学術集会プログラム・抄録集   63回   454 - 454   2019.3

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 多発性筋炎・皮膚筋炎-4 同時性重複癌を有する悪性腫瘍関連筋炎の臨床的検討

    櫻庭 未多, 門田 寛子, 五野 貴久, 山口 由衣, 渡邉 萌理, 岡崎 有佳, 渡邊 晋二, 白井 悠一郎, 小林 政司, 岳野 光洋, 寺井 千尋, 桑名 正隆

    日本リウマチ学会総会・学術集会プログラム・抄録集   63回   552 - 552   2019.3

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • シェーグレン症候群 免疫チェックポイント阻害薬投与後に発症したSjoegren症候群の臨床的特徴

    鈴木 幹人, 五野 貴久, 渡邊 晋二, 白井 悠一郎, 小林 政司, 岳野 光洋, 桑名 正隆

    日本リウマチ学会総会・学術集会プログラム・抄録集   63回   523 - 523   2019.3

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 関節リウマチの関節外病変 MTX-LPD併発RAの臨床的検討

    矢部 寛樹, 寺井 千尋, 阿部 麻衣, 渡邉 萌理, 渡邉 晋二

    日本リウマチ学会総会・学術集会プログラム・抄録集   62回   437 - 437   2018.3

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 多発性筋炎/皮膚筋炎における血清CD146の検討

    渡邉 萌理, 五野 貴久, 阿部 麻衣, 渡邊 晋二, 矢部 寛樹, 桑名 正隆, 加藤 和則, 寺井 千尋

    日本リウマチ学会総会・学術集会プログラム・抄録集   62回   666 - 666   2018.3

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 関節リウマチの関節外病変 関節リウマチにおける抗シトルリン化ペプチド抗体価と間質性肺炎の関連に関する検討

    阿部 麻衣, 杉谷 直大, 渡邉 晋二, 渡邊 萌理, 矢部 寛樹, 寺井 千尋

    日本リウマチ学会総会・学術集会プログラム・抄録集   62回   437 - 437   2018.3

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 多発性筋炎/皮膚筋炎における血清CD146の検討

    渡邉 萌理, 五野 貴久, 阿部 麻衣, 渡邊 晋二, 矢部 寛樹, 桑名 正隆, 加藤 和則, 寺井 千尋

    日本リウマチ学会総会・学術集会プログラム・抄録集   62回   666 - 666   2018.3

     More details

    Language:Japanese   Publisher:(一社)日本リウマチ学会  

    researchmap

  • 微小メサンギウムループス腎炎によりネフローゼ症候群を呈した1例

    栗原 維吹, 阿部 麻衣, 渡邊 晋二, 渡邉 萌理, 矢部 寛樹, 寺井 千尋

    日本内科学会関東地方会   639回   51 - 51   2018.2

     More details

    Language:Japanese   Publisher:日本内科学会-関東地方会  

    researchmap

  • 播種性非結核性抗酸菌症の治療中に難治性呼吸器病変を併発した全身性エリテマトーデスの一例

    阿部 麻衣, 渡邊 晋二, 渡邉 萌理, 矢部 寛樹, 寺井 千尋

    日本リウマチ学会関東支部学術集会プログラム・抄録集   28回   58 - 58   2017.12

     More details

    Language:Japanese   Publisher:日本リウマチ学会-関東支部  

    researchmap

  • 全身性強皮症に分節性動脈中膜融解を合併し、腎クリーゼによる血圧上昇から腹腔内出血を来した一例

    金子 昌平, 渡邉 萌理, 阿部 麻衣, 渡邊 晋二, 矢部 寛樹, 小島 成浩, 高木 賢治, 平井 啓之, 森下 義幸, 寺井 千尋

    日本リウマチ学会関東支部学術集会プログラム・抄録集   28回   84 - 84   2017.12

     More details

    Language:Japanese   Publisher:日本リウマチ学会-関東支部  

    researchmap

  • Management of acute gouty arthritis

    75 ( 12 )   1883 - 1887   2017.12

     More details

    Language:Japanese  

    CiNii Books

    researchmap

  • 生物学的製剤投与下での肺病変併発関節リウマチにおける新たな肺イベントに関する危険因子の同定

    杉谷直大, 五野貴久, 渡邊晋二, 渡邉萌理, 矢部寛樹, 寺井千尋

    日本リウマチ学会総会・学術集会プログラム・抄録集   61st   518 - 518   2017.3

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 脊椎関節炎に対する生物学的製剤治療効果の検討

    矢部寛樹, 杉谷直大, 渡邊晋二, 渡邉萌理, 五野貴久, 寺井千尋

    日本リウマチ学会総会・学術集会プログラム・抄録集   61st   812 - 812   2017.3

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 多発性筋炎/皮膚筋炎における筋炎特異自己抗体別にみた寛解率に関する検討

    渡邉萌理, 五野貴久, 五野貴久, 杉谷直大, 渡邊晋二, 矢部寛樹, 桑名正隆, 寺井千尋

    日本リウマチ学会総会・学術集会プログラム・抄録集   61st   824 - 824   2017.3

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • ANCA関連血管炎におけるリウマトイド因子の臨床的意義の検討

    渡邊晋二, 五野貴久, 五野貴久, 杉谷直大, 渡邉萌理, 矢部寛樹, 寺井千尋

    日本リウマチ学会総会・学術集会プログラム・抄録集   61st   550 - 550   2017.3

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 当院での脊椎関節炎に対する生物学的製剤治療効果の検討

    矢部 寛樹, 寺井 千尋, 五野 貴久, 渡邉 萌理, 渡邊 晋二, 阿部 麻衣

    日本脊椎関節炎学会誌   ( Suppl. )   43 - 43   2017.1

     More details

    Language:Japanese   Publisher:日本脊椎関節炎学会  

    researchmap

  • SAPHO症候群における臨床的特徴およびHLAタイピングの検討

    矢部 寛樹, 寺井 千尋, 五野 貴久, 渡邉 萌理, 渡邊 晋二, 阿部 麻衣, 越智 健介, 小柳 貴裕

    日本脊椎関節炎学会誌   ( Suppl. )   36 - 36   2017.1

     More details

    Language:Japanese   Publisher:日本脊椎関節炎学会  

    researchmap

  • 多発腎梗塞と大量の腎動脈出血を来し結節性多発動脈炎(PAN)との鑑別を要した分節性動脈中膜融解(segmental arterial mediolysis:SAM)の1例

    石川輝, 渡邉萌理, 杉谷直大, 渡邊晋二, 矢部寛樹, 五野貴久, 寺井千尋

    日本内科学会関東支部関東地方会   630th   76 - 76   2017

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

▼display all

Presentations

  • ANCA関連血管炎におけるリウマトイド因子の臨床的意義の検討

    渡邊晋二, 五野貴久, 杉谷直大, 渡邉萌理, 矢部寛樹, 寺井千尋

    第61回日本リウマチ学会総会・学術集会  2017.4 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • 脊椎関節炎に対する生物学的製剤治療効果の検討

    矢部寛樹, 杉谷直大, 渡邊晋二, 渡邉萌理, 五野貴久, 寺井千尋

    第61回日本リウマチ学会総会・学術集会  2017.4 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • 多発性筋炎/皮膚筋炎における筋炎特異自己抗体別にみた寛解率に関する検討

    渡邉萌理, 五野貴久, 杉谷直大, 渡邊晋二, 矢部寛樹, 桑名正隆, 寺井千尋

    2017.4 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • Rheumatoid factor is correlated with disease activity and inflammatory markers in antineutrophil cytoplasmic antibody-associated vasculitis International conference

    S. Watanabe, T. Gono, K. Nishina, N. Sugitani, E. Watanabe, H. Yabe, C. Terai

    Annual European Congress of Rheumatology, EULAR 2017  2017.6 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 既存肺病変を有する関節リウマチ患者における新規肺イベントに対する生物学的製剤の影響に関する検討

    渡邊晋二, 五野貴久, 白井悠一郎, 小林政司, 岳野光洋, 桑名正隆

    第63回日本リウマチ学会総会・学術集会  2019.4 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • 膠原病における肺エコー(シンポジウム16 関節だけじゃない,膠原病疾患におけるエコー検査活用) Invited

    渡邊晋二, 山崎宜興, 五野貴久, 桑名正隆

    第65回日本リウマチ学会総会・学術集会  2021.4 

     More details

    Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • 免疫チェックポイント阻害薬投与後に発症したSjogren症候群の臨床的特徴

    鈴木幹人, 五野貴久, 渡邊晋二, 白井悠一郎, 小林政司, 岳野光洋, 桑名正隆

    第63回日本リウマチ学会総会・学術集会  2019.4 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • 悪性腫瘍関連筋炎(CAM)における皮膚・筋症状の寛解に関する規定因子の同定

    門田寛子, 五野貴久, 山口由衣, 渡邉萌理, 岡崎有佳, 白井悠一郎, 小林政司, 岳野光洋, 寺井千尋, 桑名正隆

    第63回日本リウマチ学会総会・学術集会  2019.4 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • Treatment with Biologic DMARDs Does Not Increase Risk of Severe Pulmonary Events in Patients with Rheumatoid Arthritis and Pre-existing Lung Disease

    Watanabe Shinji, Takahisa Gono, Ryosuke Fukue, Seiji Kobayashi, Yuichiro Shirai, Mitsuhiro Takeno, Masataka Kuwana

    2019.11 

     More details

  • 血栓性微小血管障害(TMA)を主病態とした抗MDA5抗体陽性皮膚筋炎(DM)の1例

    渡邊晋二, 五野貴久, 川端真理里佐, 内山竣介, 吉田晃, 小林誠司, 白井悠一郎, 岳野光洋, 桑名正隆

    第30回日本リウマチ学会関東支部学術集会  2019.12 

     More details

  • Risk factor for serious pulmonary complication in patients with pre-existing lung disease in rheumatoid arthritis International conference

    N. Sugitani, T. Gono, S. Watanabe, E. Watanabe, H. Yabe, C. Terai

    Annual European Congress of Rheumatology, EULAR 2018  2018.6 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • 成人発症スティル病(AOSD)にARDS様の肺病変を呈した1例

    渡邊晋二

    第27回日本リウマチ学会関東支部学術集会  2016.12 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • 生物学的製剤投与下での肺病変併発関節リウマチにおける新たな肺イベントに関する危険因子の同定

    杉谷直大, 五野貴久, 渡邊晋二, 渡邉萌理, 矢部寛樹, 寺井千尋

    第61回日本リウマチ学会総会・学術集会  2017.4 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • ANCA関連血管炎患者における中耳炎の予後因子の検討

    小林政司, 門田寛子, 渡邊晋二, 白井悠一郎, 五野貴久, 岳野光洋, 桑名正隆

    第63回日本リウマチ学会総会・学術集会  2019.4 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • アダリムマブ中止後にMycobacterium aviumによる皮膚潰瘍が増悪した関節リウマチの一例

    磯村洋平, 渡邉晋二, 白井悠一郎, 小林政司, 五野貴久, 岳野光洋, 桑名正隆

    第63回日本リウマチ学会総会・学術集会  2019.4 

     More details

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • 関節リウマチにおける抗シトルリン化ペプチド抗体価と間質性肺炎の関連に関する検討

    阿部麻衣, 杉谷直大, 渡邊晋二, 渡邉萌理, 矢部寛樹, 寺井千尋

    第62回日本リウマチ学会総会・学術集会  2018.4 

     More details

    Language:Japanese  

    researchmap

  • MTX-LPD併発RAの臨床的検討

    矢部寛樹, 寺井千尋, 阿部麻衣, 渡邉萌理, 渡邊晋二

    第62回日本リウマチ学会総会・学術集会  2018.4 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • 多発性筋炎/皮膚筋炎における血清CD146の検討

    渡邉萌理, 五野貴久, 阿部, 麻衣, 渡邊晋二, 矢部寛樹, 桑名正隆, 加藤和則, 寺井千尋

    第62回日本リウマチ学会総会・学術集会  2018.4 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

▼display all

Awards

  • 第30回日本リウマチ学会関東支部学術集会 専門研修医優秀賞

    2019.12  

     More details